RE-BVS – Piemonte Repository

Sfoglia per AUTORE
PANE F
Collezione AO Ordine Mauriziano

Items : 8

Diagnostic capabilities, clinical features, and longitudinal UBA1 clonal dynamics of a nationwide VEXAS cohort. in American journal of hematology / Am J Hematol. 2024 Feb;99(2):254-262. doi: 10.1002/ajh.27169. Epub 2023 Dec 18.

2024
AO Ordine Mauriziano

Gurnari C; Pascale MR; Vitale A; Diral E; Tomelleri A; Galossi E; Falconi G; Bruno A; Crisafulli F; Frassi M; Cattaneo C; Bertoli D; Bernardi M; Condorelli A; Morsia E; Poloni A; Crisà E; Caravelli D; Triggianese P; Brussino L; Battipaglia G; Bindoli S; Sfriso P; Caroni F; Dragani M; Mallegni F; Pilo F; Firinu D; Curti A; et alii...

Italian Physicians' Perceptions about the Role of Asciminib in Later Lines Chronic Myeloid Leukemia in Clinical Practice: A GIMEMA Survey. in Journal of clinical medicine / J Clin Med. 2023 Aug 13;12(16):5267. doi: 10.3390/jcm12165267.

2023
AO Ordine Mauriziano

Breccia M; Piciocchi A; Abruzzese E; Cilloni D; Messina M; Soddu S; Castagnetti F; Stagno F; Fazi P; Iurlo A; Caocci G; Gozzini A; Intermesoli T; D'Adda M; Pane F;

Real-world efficacy and safety of luspatercept and predictive factors of response in patients with lower risk myelodysplastic syndromes with ring sideroblasts. in American journal of hematology / Am J Hematol. 2023 Aug;98(8):E204-E208. doi: 10.1002/ajh.26960. Epub 2023 May 24.

2023
AOU Alessandria
ASL Città di Torino
ASL Torino 4
AO Ordine Mauriziano

Della Porta MG; Santini V; Pasini P; Naldi I; Giordano L; Finelli C; Turrini M; Tosi P; Selleri C; Tanasi I; Sancetta R; Norata M; Frigeni M; Marchetti M; Grimaldi D; Galimberti S; Fianchi L; Ferrara F; Di Veroli A; Di Bona E; Calvisi A; Castelli A; Bono R; Occhini U; Rivoli G; Nicolino B; Molteni A; Guarini A; Genua A; et alii...

Treatment-free remission in chronic myeloid leukemia patients treated front-line with nilotinib: 10-year followup of the GIMEMA CML 0307 study. in Haematologica / Haematologica. 2022 Oct 1;107(10):2356-2364. doi: 10.3324/haematol.2021.280175.

2022
AO Ordine Mauriziano

Gugliotta G; Castagnetti F; Breccia M; Levato L; Intermesoli T; D'Adda M; Salvucci M; Stagno F; Rege-Cambrin G; Tiribelli M; Martino B; Bocchia M; Cedrone M; Trabacchi E; Cavazzini F; Porretto F; Sorà F; Simula MP; Albano F; Soverini S; Foà R; Pane F; Cavo M; Saglio G; Baccarani M; Rosti G;

Dihydroorotate dehydrogenase inhibition reveals metabolic vulnerability in chronic myeloid leukemia. in Cell death & disease / Cell Death Dis. 2022 Jun 30;13(6):576. doi: 10.1038/s41419-022-05028-9.

2022
AOU Alessandria
AO Ordine Mauriziano

Oliviero S; Taverna D; Castagnetti F; Caocci G; Mulas O; Breccia M; Abruzzese E; Iurlo A; Sora F; Geuna M; Gai M; Passoni A; Fava C; Boschi D; Giorgis M; Gaidano V; Sainas S; Molineris I; Cignetti A; Orso F; Vitale N; Houshmand M; Pane F; Lolli ML; Circosta P; Saglio G;

Prospective assessment of NGS-detectable mutations in CML patients with nonoptimal response: the NEXT-in-CML study. in Blood / Blood. 2020 Feb 20;135(8):534-541. doi: 10.1182/blood.2019002969.

2020
AO Ordine Mauriziano

Soverini S; Bavaro L; De Benedittis C; Martelli M; Iurlo A; Orofino N; Sica S; Sorà F; Lunghi F; Ciceri F; Galimberti S; Baratè C; Bonifacio M; Scaffidi L; Castagnetti F; Gugliotta G; Albano F; Russo Rossi AV; Stagno F; di Raimondo F; D'Adda M; di Bona E; Abruzzese E; Binotto G; Sancetta R; Salvucci M; Capodanno I; Girasoli M; Coluzzi S; et alii...

Pleural effusion and molecular response in dasatinib-treated chronic myeloid leukemia patients in a real-life Italian multicenter series. in Annals of hematology / Ann Hematol. 2018 Jan;97(1):95-100. doi: 10.1007/s00277-017-3144-1. Epub 2017 Oct 2.

2018
AO Ordine Mauriziano

Iurlo A; Galimberti S; Abruzzese E; Annunziata M; Bonifacio M; Latagliata R; Pregno P; Ferrero D; Sorà F; Orlandi EM; Fava C; Cattaneo D; Bucelli C; Binotto G; Pungolino E; Tiribelli M; Gozzini A; Gugliotta G; Castagnetti F; Stagno F; Rege-Cambrin G; Martino B; Luciano L; Breccia M; Sica S; Bocchia M; Pane F; Saglio G; Rosti G; et alii...

The BCR-ABL1 transcript type influences response and outcome in Philadelphia chromosome-positive chronic myeloid leukemia patients treated frontline with imatinib. in American journal of hematology / Am J Hematol. 2017 Aug;92(8):797-805. doi: 10.1002/ajh.24774. Epub 2017 May 30.

2017
AO Ordine Mauriziano

Castagnetti F; Gugliotta G; Breccia M; Iurlo A; Levato L; Albano F; Vigneri P; Abruzzese E; Rossi G; Rupoli S; Cavazzini F; Martino B; Orlandi E; Pregno P; Annunziata M; Usala E; Tiribelli M; Sica S; Bonifacio M; Fava C; Gherlinzoni F; Bocchia M; Soverini S; Bochicchio MT; Cavo M; Giovanni M; Saglio G; Pane F; Baccarani M; et alii...